These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 19798553)
1. Attitudes and practice of genetic counselors regarding anonymous testing for BRCA1/2. Ader T; Susswein LR; Callanan NP; Evans JP J Genet Couns; 2009 Dec; 18(6):606-17. PubMed ID: 19798553 [TBL] [Abstract][Full Text] [Related]
2. Clinicians' attitudes toward general screening of the Ashkenazi-Jewish population for prevalent founder BRCA1/2 and LRRK2 mutations. Shkedi-Rafid S; Ofer-Bialer G; Meiner V; Calderon-Margalit R Public Health Genomics; 2013; 16(4):174-83. PubMed ID: 23816973 [TBL] [Abstract][Full Text] [Related]
3. What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. Matloff ET; Shappell H; Brierley K; Bernhardt BA; McKinnon W; Peshkin BN J Clin Oncol; 2000 Jun; 18(12):2484-92. PubMed ID: 10856109 [TBL] [Abstract][Full Text] [Related]
4. Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results. Bradbury AR; Patrick-Miller L; Fetzer D; Egleston B; Cummings SA; Forman A; Bealin L; Peterson C; Corbman M; O'Connell J; Daly MB Clin Genet; 2011 Feb; 79(2):125-31. PubMed ID: 21039431 [TBL] [Abstract][Full Text] [Related]
5. Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discrimination. Armstrong K; Weber B; FitzGerald G; Hershey JC; Pauly MV; Lemaire J; Subramanian K; Asch DA Am J Med Genet A; 2003 Jul; 120A(3):359-64. PubMed ID: 12838555 [TBL] [Abstract][Full Text] [Related]
6. Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test. Cho MK; Sankar P; Wolpe PR; Godmilow L Am J Med Genet; 1999 Mar; 83(3):157-63. PubMed ID: 10096590 [TBL] [Abstract][Full Text] [Related]
7. Exploring genetic counselors' perceptions of usefulness and intentions to use refined risk models in clinical care based on the Technology Acceptance Model (TAM). Heinlen C; Hovick SR; Brock GN; Klamer BG; Toland AE; Senter L J Genet Couns; 2019 Jun; 28(3):664-672. PubMed ID: 30843639 [TBL] [Abstract][Full Text] [Related]
8. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Peterson EA; Milliron KJ; Lewis KE; Goold SD; Merajver SD Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):79-87. PubMed ID: 11815404 [TBL] [Abstract][Full Text] [Related]
9. Genetic counselor approaches to BRCA1/2 direct-to-consumer genetic testing results. Burke S; Mork M; Qualmann K; Woodson A; Jin Ha M; Arun B; Kaulfus M J Genet Couns; 2021 Jun; 30(3):803-812. PubMed ID: 33550665 [TBL] [Abstract][Full Text] [Related]
10. Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice. Petrucelli N; Lazebnik N; Huelsman KM; Lazebnik RS Genet Test; 2002; 6(2):107-13. PubMed ID: 12215249 [TBL] [Abstract][Full Text] [Related]
11. Impacts of genesurance considerations on genetic counselors' practice and attitudes. Thoreson E; Murphy L; Lemons J; Farach L; Wilson K; Woodson A; Wagner C J Genet Couns; 2020 Dec; 29(6):1210-1220. PubMed ID: 32432815 [TBL] [Abstract][Full Text] [Related]
12. Reproductive Endocrinologists' Utilization of Genetic Counselors for Oncofertility and Preimplantation Genetic Diagnosis (PGD) Treatment of BRCA1/2 Mutation Carriers. Goetsch AL; Wicklund C; Clayman ML; Woodruff TK J Genet Couns; 2016 Jun; 25(3):561-71. PubMed ID: 26567039 [TBL] [Abstract][Full Text] [Related]
14. Genetics and Personal Insurance: the Perspectives of Canadian Cancer Genetic Counselors. Lane M; Ngueng Feze I; Joly Y J Genet Couns; 2015 Dec; 24(6):1022-36. PubMed ID: 25925606 [TBL] [Abstract][Full Text] [Related]
15. Attitudes of obstetrician-gynecologists toward DNA testing for a genetic susceptibility to breast cancer. Rowley PT; Loader S Obstet Gynecol; 1996 Oct; 88(4 Pt 1):611-5. PubMed ID: 8841228 [TBL] [Abstract][Full Text] [Related]
16. Consumer awareness and attitudes about insurance discrimination post enactment of the Genetic Information Nondiscrimination Act. Allain DC; Friedman S; Senter L Fam Cancer; 2012 Dec; 11(4):637-44. PubMed ID: 22890887 [TBL] [Abstract][Full Text] [Related]
17. Exploring genetic counselors' perceptions of and attitudes towards schizophrenia. Monaco LC; Conway L; Valverde K; Austin JC Public Health Genomics; 2010; 13(1):21-6. PubMed ID: 19321939 [TBL] [Abstract][Full Text] [Related]
18. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. Euhus DM; Smith KC; Robinson L; Stucky A; Olopade OI; Cummings S; Garber JE; Chittenden A; Mills GB; Rieger P; Esserman L; Crawford B; Hughes KS; Roche CA; Ganz PA; Seldon J; Fabian CJ; Klemp J; Tomlinson G J Natl Cancer Inst; 2002 Jun; 94(11):844-51. PubMed ID: 12048272 [TBL] [Abstract][Full Text] [Related]
19. Impact of a genetic counseling requirement prior to genetic testing. Stenehjem DD; Au T; Sainski AM; Bauer H; Brown K; Lancaster J; Stevens V; Brixner DI BMC Health Serv Res; 2018 Mar; 18(1):165. PubMed ID: 29514700 [TBL] [Abstract][Full Text] [Related]
20. Genetic counselors' attitudes toward and practice related to psychiatric genetic counseling. Booke S; Austin J; Calderwood L; Campion M J Genet Couns; 2020 Feb; 29(1):25-34. PubMed ID: 31701601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]